Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-11-28
2006-11-28
Spector, Lorraine (Department: 1647)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C536S023400, C536S023500, C536S023520, C435S320100, C435S325000, C435S069400, C435S069500, C435S069510, C435S069520
Reexamination Certificate
active
07141392
ABSTRACT:
The present invention provides a method for providing latency to a pharmaceutically active agent. The method has application in overcoming the toxic effect of systemic administration of potent biological agents. The method comprises associating a fusion protein comprising a latency associated peptide and a proteolytic cleavage site with a pharmaceutically active agent. The fusion protein also has application in providing site specific activation to a latent pharmaceutically active agent.
REFERENCES:
patent: 6080575 (2000-06-01), Heidtmann et al.
patent: 6670147 (2003-12-01), Heidtmann et al.
patent: 2004/0110682 (2004-06-01), Heidtmann et al.
patent: 738717 (1998-07-01), None
patent: 2227159 (1998-07-01), None
Wakefield et al. 1989, Growth Factors 1:203.
Lyons et al. 1988, J Cell Biology 106:1659.
Taiple et al. 1994, J Cell Biology 124:171.
Janeway et al. 2001, Immunobiology, 5th edition, Appendix III.
Phillips, A. 2001, J of Pharm Pharmacology, 53:1169-1174.
Opal et al., 2000, Chest, 117:1162-1172.
Chemajovsky, Y., et al., “Engineering T cells and molecules for targeting joints and inflammation,”Arthritis Res. 3(suppl. 1):A4, Biomed Central, Ltd. (Apr. 2001).
Renauld, J.-C., “Class II Cytokine Receptors and Their Ligands: Key Antiviral and Inflammatory Modulators,”Nat. Rev. Immunol. 3:667-676, Nature Publishing Group (Aug. 2003).
Yoshioka, M., et al., “Effect of proteases fromPorphyromonas gingivalison adhesion molecules of human periodontal ligament fibroblast cells,”Folia Pharmacol. Jpn. 110:347-355, The Japanese Pharmacological Society (1997) Abstract only.
Adams Gillian
Chernajovsky Yuti
Dreja Hanna Stina
Queen Mary and Westfield College
Shafer Shulamith H.
Spector Lorraine
Sterne Kessler Goldstein & Fox PLLC
LandOfFree
Latent fusion protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Latent fusion protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Latent fusion protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3679171